• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 in decompensated cirrhosis.

作者信息

Rela Mohamed, Patil Vaibhav, Narasimhan Gomathy, Jothimani Dinesh

机构信息

Institute of Liver Disease and Transplantation, Dr Rela Institute and Medical Centre, Bharath Institute for Higher Education and Research, Chennai, India.

出版信息

Hepatol Int. 2020 Dec;14(6):1125-1127. doi: 10.1007/s12072-020-10092-4. Epub 2020 Sep 29.

DOI:10.1007/s12072-020-10092-4
PMID:32990918
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7522183/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14a8/7522183/e1553ff163c3/12072_2020_10092_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14a8/7522183/e1553ff163c3/12072_2020_10092_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14a8/7522183/e1553ff163c3/12072_2020_10092_Fig1_HTML.jpg

相似文献

1
COVID-19 in decompensated cirrhosis.失代偿期肝硬化患者的新型冠状病毒肺炎
Hepatol Int. 2020 Dec;14(6):1125-1127. doi: 10.1007/s12072-020-10092-4. Epub 2020 Sep 29.
2
Comparison of liver biochemical abnormality between COVID-19 patients with liver cirrhosis versus COVID-19 alone and liver cirrhosis alone: A STROBE observational study.新冠病毒肺炎合并肝硬化患者与单纯新冠病毒肺炎患者及单纯肝硬化患者肝脏生化异常情况的比较：一项加强观察性研究报告（STROBE）
Medicine (Baltimore). 2021 May 14;100(19):e25497. doi: 10.1097/MD.0000000000025497.
3
Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis.一名患有COVID-19和失代偿期肝硬化的患者出现急性免疫性血小板减少性紫癜。
BMJ Case Rep. 2020 Jul 7;13(7):e236815. doi: 10.1136/bcr-2020-236815.
4
Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection.比较不同预后评分系统对因 SARS-CoV-2 感染住院的肝硬化患者的预测效果。
Ann Hepatol. 2021 Nov-Dec;25:100350. doi: 10.1016/j.aohep.2021.100350. Epub 2021 Apr 14.
5
Proposed mechanism for increased COVID-19 mortality in patients with decompensated cirrhosis.失代偿期肝硬化患者COVID-19死亡率增加的潜在机制。
Hepatol Int. 2020 Sep;14(5):884-885. doi: 10.1007/s12072-020-10084-4. Epub 2020 Sep 4.
6
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study).既往肝脏疾病与 SARS-CoV-2 感染患者的不良结局相关；APCOLIS 研究（亚太肝脏研究学会 COVID-19 肝脏损伤谱研究）。
Hepatol Int. 2020 Sep;14(5):690-700. doi: 10.1007/s12072-020-10072-8. Epub 2020 Jul 4.
7
Health Conditions Associated With Severe Illness From COVID-19 Among Individuals With Serious Mental Illness.严重精神疾病患者中与COVID-19重症相关的健康状况
Psychiatr Serv. 2021 Apr 1;72(4):468-469. doi: 10.1176/appi.ps.202000300. Epub 2020 Nov 19.
8
A SARS-Cov2-negative corona victim.一名新冠病毒检测呈阴性的新冠肺炎患者。
Clin Res Cardiol. 2020 Dec;109(12):1569-1572. doi: 10.1007/s00392-020-01668-z. Epub 2020 May 9.
9
COVID-19 - Computed tomography findings in two patients in Petrópolis, Rio de Janeiro, Brazil.新冠病毒病——巴西里约热内卢彼得罗波利斯市两名患者的计算机断层扫描结果
Rev Soc Bras Med Trop. 2020 Apr 22;53:e20200147. doi: 10.1590/0037-8682-0147-2020. eCollection 2020.
10
Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis.冠状病毒病（COVID-19）与肝脏：全面系统综述和荟萃分析。
Hepatol Int. 2020 Sep;14(5):711-722. doi: 10.1007/s12072-020-10071-9. Epub 2020 Jul 4.

引用本文的文献

1
Critical Update on the Diagnosis and Management of COVID-19 in Advanced Cirrhosis and Liver Transplant Recipients.晚期肝硬化和肝移植受者中COVID-19诊断与管理的重要更新
J Clin Transl Hepatol. 2021 Dec 28;9(6):947-959. doi: 10.14218/JCTH.2021.00228. Epub 2021 Sep 18.
2
Coronavirus disease 2019 in liver transplant patients: Clinical and therapeutic aspects.肝移植患者的2019冠状病毒病：临床与治疗方面
World J Hepatol. 2021 Oct 27;13(10):1299-1315. doi: 10.4254/wjh.v13.i10.1299.
3
Clinical outcomes in COVID-19 and cirrhosis: a systematic review and meta-analysis of observational studies.

本文引用的文献

1
COVID-19 and the liver.COVID-19 与肝脏。
J Hepatol. 2020 Nov;73(5):1231-1240. doi: 10.1016/j.jhep.2020.06.006. Epub 2020 Jun 15.
2
High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry.患有慢性肝病和肝硬化的患者感染新型冠状病毒的死亡率很高：一项国际登记处的初步结果
J Hepatol. 2020 Sep;73(3):705-708. doi: 10.1016/j.jhep.2020.05.013. Epub 2020 May 21.
3
SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
COVID-19 与肝硬化的临床结局：观察性研究的系统评价和荟萃分析。
BMJ Open Gastroenterol. 2021 Oct;8(1). doi: 10.1136/bmjgast-2021-000739.
4
Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.由（SARS-CoV-2）感染引起的冠状病毒病（COVID-19）：人类肠道微生物组的真正挑战。
Front Cell Infect Microbiol. 2020 Dec 9;10:575559. doi: 10.3389/fcimb.2020.575559. eCollection 2020.
5
Post liver transplant recurrent and de novo viral infections.肝移植后复发和新发病毒感染。
Best Pract Res Clin Gastroenterol. 2020 Jun-Aug;46-47:101689. doi: 10.1016/j.bpg.2020.101689. Epub 2020 Sep 26.
SARS-CoV-2 感染肝脏直接导致 COVID-19 患者肝损伤。
J Hepatol. 2020 Oct;73(4):807-816. doi: 10.1016/j.jhep.2020.05.002. Epub 2020 May 11.
4
Central nervous system manifestations of COVID-19: A systematic review.COVID-19 相关的中枢神经系统表现：一项系统性综述。
J Neurol Sci. 2020 Jun 15;413:116832. doi: 10.1016/j.jns.2020.116832. Epub 2020 Apr 11.
5
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
6
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.